证券代码：301329 证券简称：信音电子 公告编号：2025-036 信音电子(中国)股份有限公司 第六届监事会第二次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 经与会监事认真审议，会议通过了以下议案并形成如下决议： （一）审议通过了《关于<2025 年半年度报告>全文及其摘要的议案》 监事会认为董事会编制和审议的《2025 年半年度报告》全文及其摘要的程 序符合法律、行政法规和中国证监会、深圳证券交易所的有关规定，报告内容真 实、准确、完整地反映了公司的实际情况，不存在虚假记载、误导性陈述或者重 大遗漏。 具体内容详见公司于同日在巨潮资讯网（http://www.cninfo.com.cn）披露 的《2025 年半年度报告》全文及其摘要。 表决结果：3 票同意、0 票反对、0 票弃权。 （二）审议通过了《关于公司 2025 年半年度利润分配预案的议案》 经审议，监事会认为：在保证公司正常经营前提下，为了更好的兼顾股东利 益，使全体股东分享公司经营成果，认为董事会制定的 2025 年中期利润分配预 案与公司业绩成长性相匹配，符合公司确定的利 ...

Meeting Overview - The fourth meeting of the Supervisory Board of Beijing Zhongke Haixun Digital Technology Co., Ltd. was held on August 25, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1] Resolutions Passed - The Supervisory Board approved the "2025 Half-Year Report and its Summary," affirming that the report accurately reflects the company's situation without any misleading statements or omissions [2][3] - The board agreed on the "2025 Half-Year Provision for Credit Impairment Losses and Asset Impairment Reserves," stating that the provisions align with accounting standards and accurately represent the company's financial status [2][3] - The "Special Report on the Storage and Use of Raised Funds for the First Half of 2025" was approved, confirming that the management of raised funds complies with regulations and accurately reflects their usage [3] - The board approved the amendment of the company's Articles of Association, which will be submitted for review at the upcoming extraordinary shareholders' meeting [4][5] - The proposal to reappoint the accounting firm for the 2025 fiscal year was approved, with the firm Rongcheng Accounting Firm (Special General Partnership) designated for the audit [5]

或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 按照中国证券监督管理委员会《上市公司募集资金监管规则》、上海证券交 易所《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有 关规定，南京麦澜德医疗科技股份有限公司（以下简称"公司"或"本公司"）董事会 编制了 2025 年半年度（以下简称"报告期内"）募集资金存放与实际使用情况的专 项报告如下： 一、募集资金基本情况 （一）实际募集资金金额及资金到账情况 根据中国证券监督管理委员会出具的《关于同意南京麦澜德医疗科技股份有 限公司首次公开发行股票注册的批复》（证监许可〔2022〕1189 号），公司获准 向社会公众公开发行人民币普通股（A 股）2,500 万股，每股面值为人民币 1 元， 每股发行价格为人民币 40.29 元，募集资金总额为人民币 100,725.00 万元，扣除各 项发行费用人民币 9,749.15 万元（不含增值税）后，实际募集资金净额为人民币 行的资金到位情况进行了审验，并出具了天衡验字(2022)00085 号《验资报告》。 公司已对募集资金进行了专户存储，并与保荐机构、专户存储募集资金的相 关银行签 ...

Fundraising Overview - The company raised a total of 533,333,400 shares at an issuance price of 5.44 RMB per share, resulting in net proceeds of approximately 2.80 billion RMB after deducting issuance costs [1][2] - As of June 30, 2025, the balance in the fundraising special account was 348,404,916.35 RMB, which includes bank interest after deducting fees [1][2] Fund Management - The company revised its fundraising management system to enhance the management and usage of raised funds, ensuring investor protection [1] - The company has established special accounts for fundraising in compliance with relevant laws and regulations, with oversight agreements signed with six commercial banks [1][2] Fund Usage in 2025 - The total amount of funds used for investment projects in the first half of 2025 was 0.40 billion RMB, with a cumulative investment of 24.96 billion RMB [2][3] - There were no significant changes in the total investment amount committed to fundraising projects, and the actual investment progress aligned with the planned investment [2][3] Changes in Fund Usage - The company changed the project "Post-Market Capability Enhancement Project" to "Investment in Customized Deep-Sea Operation and Maintenance Mother Ship Project," with a planned use of 287.58 million RMB [2][3] - The company canceled two sub-projects under the "Jiangsu Binhai Testing Base Project," reducing the investment amount by 89.76 million RMB, leaving a planned use of 448.51 million RMB for the project [2][3] Compliance and Reporting - The company strictly adheres to legal regulations and its fundraising management system, ensuring that the storage, usage, and management of raised funds are legal and effective [2][3] - All disclosed information regarding fundraising has been timely, truthful, accurate, and complete [2][3]

上海电气风电集团股份有限公司 （第 5 版 经第二届董事会第十五次会议审议通过） 第一章 总 则 第一条 为加强、规范公司募集资金的管理和使用，提高募集资金使用效率， 确保资金使用安全，切实保护投资者利益，根据《中华人民共和国证券法》、中 国证监会《上市公司募集资金监管规则》、上海证券交易所《科创板股票上市规 则》 《科创板上市公司自律监管指引第 1 号——规范运作》 《科创板上市公司自律 监管指引第 3 号——科创属性持续披露及相关事项》等法律、法规和规范性文件 （以下统称"法律法规"），以及公司章程的相关规定，结合公司实际情况，制定 本制度。 第二条 本制度所称"募集资金"是指公司通过发行股票或者其他具有股权 性质的证券，向投资者募集并用于特定用途的资金，但不包括公司实施股权激励 计划募集的资金。 第三条 公司董事会应当持续关注募集资金存放、管理和使用情况，有效防 范投资风险，提高募集资金使用效益。 第四条 董事和高级管理人员应当勤勉尽责，确保募集资金安全，不得操控 公司擅自或变相改变募集资金用途。 第五条 公司控股股东、实际控制人及其他关联人不得占用公司募集资金， 不得利用公司募集资金投资项目（以下简称 ...

Fundraising Overview - The company raised a total of RMB 2,002,412,490.32 through its initial public offering, with a net amount of RMB 1,910,616,719.65 after deducting related expenses [1][2] - As of June 30, 2025, the company has invested RMB 116,085.45 million of the raised funds, with RMB 102,895.06 million used in previous years and RMB 13,190.38 million in 2025 [2][6] Fund Management - The company has established a fundraising management system in compliance with relevant laws and regulations to ensure effective use and protection of investor rights [2][3] - A tripartite supervision agreement was signed with the underwriter and the bank to manage the raised funds [3][4] Fund Usage and Balance - As of June 30, 2025, the remaining balance of the raised funds is RMB 85,704.81 million, with RMB 80,000.00 million in fixed deposits and RMB 5,704.81 million in the special account [2][6] - The company has not used idle funds to temporarily supplement working capital in the first half of 2025 [7][21] Cash Management - The company has approved the use of idle funds for cash management, allowing investments in safe and liquid products with a maximum limit of RMB 100,000 million for idle raised funds and RMB 30,000 million for idle self-owned funds [8][22] - As of June 30, 2025, the company achieved cash management income of RMB 232.45 million [23] Project Investment and Adjustments - The company has made adjustments to the investment structure of its projects, extending the construction period for the R&D technology center to December 2025 and relocating the electronic information equipment production base project to Nanjing, with a new completion date of December 2026 [21][24] - The company has used RMB 355.47 million of raised funds to replace self-owned funds used for project personnel costs in the first half of 2025 [21][25] Compliance and Reporting - The company adheres to the regulations set by the China Securities Regulatory Commission and the Shanghai Stock Exchange regarding the management and disclosure of raised funds, ensuring timely and accurate reporting [19][20]

Fundraising Overview - The company raised a total of RMB 266,932.80 million by issuing 40.08 million shares at a price of RMB 66.60 per share, with net proceeds after fees amounting to RMB 252,351.50 million as of April 7, 2022 [1][2] - As of June 30, 2025, the remaining balance in the fundraising account is RMB 63,327,483.63 after accounting for various expenditures and interest income [1][2] Fund Management - The company has established a fundraising management system in compliance with relevant laws and regulations to ensure proper management and usage of the raised funds [1][2] - Multiple tripartite agreements have been signed with banks and underwriters to oversee the storage of the fundraising account [2] Fund Usage - As of June 30, 2025, the total amount used from the raised funds is RMB 1,985,933,395.89, leaving a balance of RMB 537,581,564.11 in the fundraising account as of the end of 2024 [1][2] - The company has not used idle funds to temporarily supplement working capital as of June 30, 2025 [3][4] Investment Projects - The company has invested RMB 179,861,564.61 in the "High Integration, High Performance RF Module R&D Project" as of June 30, 2025 [5][6] - The "Integrated Circuit Production Testing Project" has been terminated, and the remaining funds have been redirected to the new RF module project [5][6] Cash Management - The company has approved the use of idle funds for cash management, with a limit of RMB 70,000 million for safe and liquid investment products [3][4] - As of June 30, 2025, the company has not used any excess funds to permanently supplement working capital or repay bank loans [5][6] Reporting and Compliance - The company has complied with disclosure obligations regarding the use and management of raised funds, ensuring timely and accurate reporting [8][9] - There are no significant issues in the usage and disclosure of the raised funds, and the company has adhered to regulatory requirements [8][9]

Summary of Key Points Core Viewpoint The report outlines the fundraising activities and the actual usage of the raised funds by Guangdong Boliv Technology Co., Ltd. for the first half of 2025, emphasizing compliance with regulatory requirements and the effective management of funds. Fundraising Overview - The company raised a total of RMB 647.75 million by issuing 25 million shares at RMB 25.91 per share, with a net amount of RMB 579.54 million after deducting issuance costs of RMB 68.21 million [1]. - As of June 30, 2025, the company had no remaining balance of the raised funds, having utilized all funds for operational needs and project investments [1][2]. Fund Usage and Management - The company permanently supplemented its working capital with RMB 77.90 million from the remaining funds, including interest [1]. - The company has established a dedicated account management system for the raised funds, ensuring compliance with relevant regulations and protecting investor interests [1][2]. - As of June 30, 2025, the company had no instances of using idle funds for cash management [2]. Project Investment and Surplus Funds - The company has completed several projects, including the lightweight vehicle lithium-ion battery project, the R&D center construction, and the information management system project, with surplus funds being permanently allocated to working capital [2][3]. - The surplus funds were primarily due to cost-saving measures such as optimizing production processes and utilizing domestic suppliers, which reduced overall project costs [2][3]. - The company has not changed the use of raised funds for any projects during the reporting period [2][3]. Compliance and Reporting - The company has adhered to all legal and regulatory requirements regarding the management and disclosure of raised funds, with no violations reported [2][3]. - There were no instances of multiple financings or changes in project feasibility during the reporting period [2][3].

南京中央商场（集团）股份有限公司 募集资金管理制度 第四条 公司的董事和高级管理人员应当勤勉尽责，督促公司规范使用募集 资金，自觉维护公司募集资金安全，不得参与、协助或纵容公司擅自或变相改变 募集资金用途。 公司控股股东、实际控制人不得直接或者间接占用或者挪用公司募集资金， 不得利用公司募集资金及募集资金投资项目（以下简称"募投项目"）获取不正 当利益。 第五条 保荐机构应当按照《证券发行上市保荐业务管理办法》及《上市公 司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等文件对公司 募集资金的管理和使用履行保荐职责，进行持续督导工作。 南京中央商场（集团）股份有限公司 募集资金管理制度 第一章 总则 第一条 为了规范南京中央商场（集团）股份有限公司（以下简称"公司"） 募集资金的管理和运用，提高募集资金使用效率，最大程度地保障投资者的合法 利益，依据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司监 管指引第 2 号——上市公司募集资金管理和使用的监管要求》《上海证券交易所 上市公司自律监管指引第 1 号——规范运作》等有关法律法规、规范性文件和《南 京中央商场（集团）股份有限公司章程 ...

广东博力威科技股份有限公司 募集资金管理制度 广东博力威科技股份有限公司 第一章 总则 第一条 为了规范广东博力威科技股份有限公司（以下简称"公司"）募集资 金的使用与管理，提高募集资金使用效益，保护投资者的合法权益，根据《中华人 民共和国公司法》《中华人民共和国证券法》《上海证券交易所科创板股票上市规 则》等有关法律、法规、规范性文件和《广东博力威科技股份有限公司章程》（以 下简称"《公司章程》"）的有关规定，制定本制度。 第二条 本制度适用于公司通过发行股票或者其他具有股权性质的证券，向投 资者募集并用于特定用途的资金监管，但不包括公司为实施股权激励计划募集的资 金监管。 第三条 本制度是公司对募集资金使用和管理的基本行为准则。如募集资金投 资项目（以下简称"募投项目"）通过公司的子公司或公司控制的其他企业实施的， 公司应当确保该子公司或控制的其他企业遵守本制度。 第四条 公司董事会应当持续关注募集资金存放、管理和使用情况，有效防范 投资风险，提高募集资金使用效益。 公司董事、高级管理人员应当勤勉尽责，确保公司募集资金安全，不得操控公 司擅自或者变相改变募集资金用途。 第五条 公司募集资金应当专款专用。公 ...